Yates D B
Research Department, Boots Pharmaceuticals, Nottingham, England.
Am Heart J. 1991 Mar;121(3 Pt 1):974-83. doi: 10.1016/0002-8703(91)90229-b.
Flosequinan is a novel quinolone with cardiovascular activity that is likely to be of value in the treatment of both heart failure and hypertension. Data generated from animal studies indicate that flosequinan produces dilatation in both veins and arteries, with little associated reflex tachycardia. The compound shows some positive inotropic effects, but the potency is very species dependent. The mode of action of flosequinan seems to involve intracellular calcium handling.
氟司喹南是一种具有心血管活性的新型喹诺酮类药物,可能在治疗心力衰竭和高血压方面具有价值。动物研究产生的数据表明,氟司喹南可使静脉和动脉均扩张,且几乎不伴有反射性心动过速。该化合物显示出一些正性肌力作用,但其效力非常依赖于物种。氟司喹南的作用模式似乎涉及细胞内钙的处理。